A Swedish company is making a $5.6 billion (£4.5 billion) deal to buy a Northwich, England-based veterinary pharmaceuticals company with a Portland office. The Dechra Veterinary Products deal could be one of the biggest private equity transactions of 2023 in the United Kingdom.

Taro Pharmaceutical received a $38/share offer from Sun Pharma last month. Read why the deal represent a decent premium to TARO stock’s market value at the time.

The man behind the largest pharmaceutical seizure in the Lake Worth Police Department’s history was sentenced to just under six years in federal prison.

Doctors and pharmacists in Florida aren’t strangers to diminished inventories. Here’s a closer look at the current shortage and how the state is managing.

A pharmaceutical company being sued for state and federal antitrust law violations has agreed on a settlement with 41 states and the District of Columbia, according to an Ohio Attorney General’s Office release.

A manufacturer, distributor and marketer of veterinary pharmaceuticals with its North American headquarters in the Kansas City area has agreed to a multi-billion-dollar buyout.

The average one-year price target for Rohto Pharmaceutical (TYO:4527) has been revised to 3,109.54 / share. This is an increase of 8.11% from the prior estimate of 2,876.40 dated May 10, 2023. The price target is an average of many targets provided by analysts.

Sometimes a lot of R&D goes into only marginally effective drugs. Other times, drugs with relatively minimal amounts of R&D turn out to have a lot of value.